AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IONIS PHARMACEUTICALS INC Director's Dealing 2013

Jun 26, 2013

30591_dirs_2013-06-26_5ad90766-b1be-4e2f-9e0f-88f9b31aabb0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2013-06-25

Reporting Person: Castleman Breaux (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities owned	0	Direct